- Home
- XTLB vs CLRO Comparison
XTLB vs CLRO Comparison
Compare XTLB & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTLB
- CLRO
- Stock Information
- Founded
- XTLB 1993
- CLRO 1983
- Country
- XTLB Israel
- CLRO United States
- Employees
- XTLB N/A
- CLRO N/A
- Industry
- XTLB Biotechnology: Pharmaceutical Preparations
- CLRO Radio And Television Broadcasting And Communications Equipment
- Sector
- XTLB Health Care
- CLRO Technology
- Exchange
- XTLB Nasdaq
- CLRO Nasdaq
- Market Cap
- XTLB 15.6M
- CLRO 13.9M
- IPO Year
- XTLB 2005
- CLRO N/A
- Fundamental
- Price
- XTLB $2.36
- CLRO $0.60
- Analyst Decision
- XTLB
- CLRO
- Analyst Count
- XTLB 0
- CLRO 0
- Target Price
- XTLB N/A
- CLRO N/A
- AVG Volume (30 Days)
- XTLB 5.8K
- CLRO 19.7K
- Earning Date
- XTLB 11-20-2024
- CLRO 11-07-2024
- Dividend Yield
- XTLB N/A
- CLRO 84.53%
- EPS Growth
- XTLB N/A
- CLRO N/A
- EPS
- XTLB N/A
- CLRO N/A
- Revenue
- XTLB N/A
- CLRO $14,969,000.00
- Revenue This Year
- XTLB N/A
- CLRO N/A
- Revenue Next Year
- XTLB N/A
- CLRO N/A
- P/E Ratio
- XTLB N/A
- CLRO N/A
- Revenue Growth
- XTLB N/A
- CLRO N/A
- 52 Week Low
- XTLB $0.75
- CLRO $0.53
- 52 Week High
- XTLB $4.99
- CLRO $2.48
- Technical
- Relative Strength Index (RSI)
- XTLB 40.17
- CLRO 49.86
- Support Level
- XTLB $2.25
- CLRO $0.57
- Resistance Level
- XTLB $2.56
- CLRO $0.63
- Average True Range (ATR)
- XTLB 0.10
- CLRO 0.03
- MACD
- XTLB -0.01
- CLRO 0.00
- Stochastic Oscillator
- XTLB 32.35
- CLRO 57.86
About XTLB XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.